Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coagulopathy Associated With Coronavirus disease19 (CA-COVID19) A Multi-Centre Observational Study in UK

NCT04405232 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04405232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04405232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coagulopathy Associated With Coronavirus disease19 (CA-COVID19) A Multi-Centre Observational Study in UK
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Unknown status
Start date
May 25, 2020
Completion date
June 25, 2021
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulation, bleeding, covid, thrombosis